MarketLens

What Does YUVIWEL's FDA Approval Mean for Ascendis Pharma

6 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What is the Significance of Lynavoy's FDA Approval for GSK

3 months ago

What Does Teva's Recent FDA Acceptance Mean for Investors

6 months ago

What Does the FDA Warning Mean for Medline's Operations

5 months ago

What Does Ultragenyx's Latest FDA Clearance Mean for Investors

5 months ago

Ultragenyx Pharmaceutical Inc. (RARE) Discusses FDA Approval of Gene Therapy for Glycogen Storage Disease Type 1a Transcript

Ultragenyx's gene therapy for glycogen storage disease type 1a received FDA approval, marking a key regulatory milestone. The approval could drive revenue growth if commercial launch executes well.

RARE

Stock News•1 months ago

Ascendis Pharma Reports Second Quarter 2026 Financial Results

Ascendis Pharma reported Q2 2026 product revenue of €315 million, up 105% year-over-year, driven by YORVIPATH at €252 million, SKYTROFA at €55 million, and YUVIWEL at €8 million.

ASND

Stock News•2 months ago

U.S. Food and Drug Administration Accepts BioMarin's Supplemental New Drug Application for Full Approval of VOXZOGO® (vosoritide) for Children With Achondroplasia

FDA accepted BioMarin's sNDA for full approval of VOXZOGO in achondroplasia, with a PDUFA target date of Feb. 28, 2027, based on long-term efficacy data including adult height and body proportionality...

BMRN

Breaking News

Low Volatility Factor

Startup Funding

Top Headlines

View More →

Stock News•29 minutes ago

Samsung backs Nvidia AI chip rival in $230 million funding round as GPU alternatives boom

Stock News•1 hour ago

Why the Market Dipped But Microsoft (MSFT) Gained Today

Stock News•1 hour ago

Microsoft Just Made a Move That Could Put More Pressure on Its Azure Business. Here's Why It Could Turn Out Great for the Stock

Stock News•1 hour ago

Nasdaq Tests Key Level On AI Warnings Ahead Of Fed Meeting; Nvidia, Sandisk, Micron Tumble

Stock News•2 hours ago

What Does YUVIWEL's FDA Approval Mean for Ascendis Pharma

Exclusive Content for Pro Members

Related Articles

What is the Significance of Lynavoy's FDA Approval for GSK

What Does Teva's Recent FDA Acceptance Mean for Investors

What Does the FDA Warning Mean for Medline's Operations

What Does Ultragenyx's Latest FDA Clearance Mean for Investors

Category

You may also like

Ultragenyx Pharmaceutical Inc. (RARE) Discusses FDA Approval of Gene Therapy for Glycogen Storage Disease Type 1a Transcript

Ascendis Pharma Reports Second Quarter 2026 Financial Results

U.S. Food and Drug Administration Accepts BioMarin's Supplemental New Drug Application for Full Approval of VOXZOGO® (vosoritide) for Children With Achondroplasia

Breaking News

Featured Articles

DoorDash (DASH): Founder Selling Signals Liquidity, Not Lack of Confidence Amid Robust Growth

Sea Limited's Growth Momentum Outweighs COO's Programmed De-risking

Arista Networks' AI Momentum Encounters Founder's Planned Profit-Taking

Top Headlines

Samsung backs Nvidia AI chip rival in $230 million funding round as GPU alternatives boom

Why the Market Dipped But Microsoft (MSFT) Gained Today

Microsoft Just Made a Move That Could Put More Pressure on Its Azure Business. Here's Why It Could Turn Out Great for the Stock

Nasdaq Tests Key Level On AI Warnings Ahead Of Fed Meeting; Nvidia, Sandisk, Micron Tumble

Trump phones Nvidia's Huang at All-In Summit, calls data center opposition a ‘hoax'